Smelling the diagnosis A review on the use of scent in diagnosing disease

Netherlands Journal of Medicine

Volumn 71, Issue 6, 2013, Pages 300-307

  Bijland, L R ^a   Bomers, M K ^a   Smulders, Y M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Detection dog; Electronic nose; Odours; Scent detection; Smell

Indexed keywords

ASTHMA; BLADDER CANCER; BREAST CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; DIABETES MELLITUS; DOG; ELECTRONIC NOSE; HUMAN; INTESTINE INFECTION; LIVER CIRRHOSIS; LUNG CANCER; LUNG INFECTION; MELANOMA; METABOLIC DISORDER; NONHUMAN; ODOR; OVARY CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; SMELLING;

ANIMALS; BIOSENSING TECHNIQUES; BREATH TESTS; GASES; HUMANS; INFECTION; METABOLIC DISEASES; NEOPLASMS; ODORS; SMELL;

EID: 84882249036     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Mitruka BM. Gas chromatographic applications in microbiology and medicine. In: Mitruka BM, ed, Gas chromatographic applications in microbiology and medicine. New York: John Wiley and Sons; 1975; 349-74.
2. Williams H, Pembroke A. Sniffer dogs in the melanoma clinic? Lancet. 1989;1:734.
3. Persaud K, Dodd G. Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose. Nature. 1982;299:352-5.
4. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
5. Ehmann R, Boedeker E, Friedrich U, et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012;39:669-76.
6. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A. 1971;68:2374-6.
7. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem. 1985;31:1278-82.
8. Bajtarevic A, Ager C, Pienz M, et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer. 2009;9:348.
9. D'Amico A, Pennazza G, Santonico M, et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer. 2010;68:170-6.
10. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron. 2003;18:1209-18.
11. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med. 2005;171:1286-91.
12. Dragonieri S, Annema JT, Schot R, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer. 2009;64:166-70.
13. Horvath G, Andersson H, Paulsson G. Characteristic odour in the blood reveals ovarian carcinoma. BMC Cancer. 2010;10:643.
14. Horvath G, Chilo J, Lindblad T. Different volatile signals emitted by human ovarian carcinoma and healthy tissue. Future Oncol. 2010;6:1043-9.
15. Parkin DM. Gloabal cancer statistics in the year 2000. Lancet Oncology. 2001;2:533-43.
16. Phillips M, Cataneo RN, Ditkoff BA, et al. Volatile markers of breast cancer in the breath. Breast J. 2003;9:184-91.
17. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006;5:30-9.
18. Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J. Volatile biomarkers in the breath of women with breast cancer. J Breath Res. 2010;4:026003.
19. Willis CM, Church SM, Guest CM, et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ. 2004;329:712.
20. Bernabei M, Pennazza G, Santortico M, et al. A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose. Sens Actuat B. 2008;131:1-4.
21. Sonoda H, Kohnoe S, Yamazato T, et al. Colorectal cancer screening with odour material by canine scent detection. Gut. 2011;60:814-9.
22. Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut. 1996;39:722-5.
23. UK colorectal cancer screening pilot group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ. 2004;329:133.
24. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-7.
25. Peng G, Hakim M, Broza YY, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer. 2010;103:542-51.
26. Pickel D, Manucy GP, Walker DB, Hall SB, Walker JC. Evidence for canine olfactory detection of melanoma. Appl Anim Behav Sci. 2004;89:107-16.
27. D'Amico A, Bono R, Pennazza G, et al. Identification of melanoma with a gas sensor array. Skin Res Technol. 2008;14:226-36.
28. Kellet CE. The early history of gas gangrene. Ann Med Hist. 1939;1:452-9
29. Dubois R, Dubois J. The White Plague: Tuberculosis, Man and Society. Boston: Little, Brown and Company; 1952.
30. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. American Thoracic Society. Am J Respir Crit Care Med. 2000;161:1376-95.
31. Poling A, Weetjens B, Cox C, Beyene N, Sully A. Using giant African pouched rats to detect land mines: Another victory for operant conditioning. J Appl Behav Anal. 2011;44:351-5.
32. Mgode GF, Weetjens BJ, Nawrath T, et al. Diagnosis of tuberculosis by trained African giant pouched rats and confounding impact of pathogens and microflora of the respiratory tract. J Clin Microbiol. 2012;50:274-80.
33. Mahoney A, Weetjens BJ, Cox C, et al. Pouched Rats' Detection of Tuberculosis in Human Sputum: Comparison to Culturing and Polymerase Chain Reaction. Tuberc Res Treat. 2012;2012:716-989.
34. Suckling DM, Sagar RL. Honeybees Apis mellifera can detect the scent of Mycobacterium tuberculosis. Tuberculosis. 2011;91:327-8.
35. Phillips M, Basa-Dalay V, Bothamley G, et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis. 2010;90:145-51.
36. Savelev SU, Perry JD, Bourke SJ, et al. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis. Lett Appl Microbiol. 2011;52:610-3.
37. Poulton J, Tarlow MJ. Diagnosis of rotavirus gastroenteritis by smell. Arch Dis Child. 1987;62:851-2.
38. Burdette SD, Bernstein JM. Does the nose know? The odiferous diagnosis of Clostridium difficile-associated diarrhea. Clin Infect Dis. 2007;44:1142.
39. Bomers MK, van Agtmael MA, Luik H, van Veen MC, Vandenbroucke-Grauls CMJE, Smulders YM. Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ. 2012;345:e7396.
40. Garner CE, Smith S, Costello BD, et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007;21:1675-88.
41. Pavlou AK, Magan N, Sharp D, Brown J, Barr H, Turner AP. An intelligent rapid odour recognition model in discrimination of Helicobacter pylori and other gastroesophageal isolates in vitro. Biosens Bioelectron. 2000;15:333-42.
42. Chen M, Daly M, Williams N, Williams S, Williams C, Williams G. Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ. 2000;321:1565-6.
43. Strong V, Brown S, Huyton M, Coyle H. Effect of trained Seizure Alert Dogs on frequency of tonic-clonic seizures. Seizure. 2002;11:402-5.
44. Brown SW, Strong V. The use of seizure-alert dogs. Seizure. 2001;10:39-41.
45. Greiter MB, Keck L, Siegmund T, Hoeschen C, Oeh U, Paretzke HG. Differences in exhaled gas profiles between patients with type 2 diabetes and healthy controls. Diabetes Technol Ther. 2010;12:455-63.
46. Phillips M, Cataneo RN, Cheema T, Greenberg J. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta. 2004;344:189-94.
47. Chen S, Mahadevan V, Zieve L. Volatile fatty acids in the breath of patients with cirrhosis of the liver. J Lab Clin Med. 1970;75:622-7.
48. Van den Velde S, Nevens F, Van Hee P, van Steenberghe D, Quirynen M. GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;875:344-8.
49. Dragonieri S, Schot R, Mertens BJA, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol. 2007;120:856-62.
50. Fens N, Roldaan AC, van der Schee MP, et al. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy. 2011;41:1371-8.
51. Fens N, De Nijs SB, Peters S, et al. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J. 2011;38:1301-9.
52. Phillips M, Sabas M, Greenberg J. Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol. 1993;46:861-4.
53. Waggoner LP, Jones M, Williams M, Johnston JM, Edge C, Petrousky JA. Effects of extraneous odors on canine detection. In: DePersia AT, Pennella JJ (Eds.), Enforcement and Securities Technologies, Proc. SPIE, vol. 3575, 1998:355-62.
54. Schiffman SS, Kermani BG, Nagle HT. Analysis of medication off-odors using an electronic nose. Chem Senses. 1997;22:119-28.
55. The science of smell Part 1: Odor perception and physiological response. Iowa State University. 2004. Accessed at Air Quality and Animal Agriculture Web page: http://www.extension.iastate.edu/airquality.
56. Rouquier S, Blancher A, Giorgi D. The olfactory receptor gene repertoire in primates and mouse: evidence for reduction of the functional fraction in primates. Proc Natl Acad Sci U S A. 2000;14:2870-4.